| Autor: |
Girbardt, Christian, Busch, Catharina, Al-Sheikh, Mayss, Gunzinger, Jeanne Martine, Invernizzi, Alessandro, Xhepa, Alba, Unterlauft, Jan Darius, Rehak, Matus |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Girbardt, Christian; Busch, Catharina; Al-Sheikh, Mayss; Gunzinger, Jeanne Martine; Invernizzi, Alessandro; Xhepa, Alba; Unterlauft, Jan Darius; Rehak, Matus (2021). Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines-A Case Series. Vaccines, 9(11) MDPI 10.3390/vaccines9111349 |
| DOI: |
10.48350/162761 |
| Popis: |
BACKGROUND To describe cases of retinal vascular events shortly after administration of mRNA or adenoviral-vectored COVID-19 vaccines. DESIGN Retrospective, multicenter case series. METHODS Six cases of retinal vascular events shortly after receiving COVID-19 vaccines. RESULTS A 38-year-old, otherwise healthy male patient presented with branch retinal arterial occlusion four days after receiving his second dose of SARS-CoV-2 vaccination with Comirnaty�� (BioNTech��, Mainz, Germany; Pfizer��, New York City, NY, USA). An 81-year-old female patient developed visual symptoms twelve days after the second dose of SARS-CoV-2 vaccination with Comirnaty�� and was diagnosed with a combined arterial and venous occlusion in her right eye. A 40-year-old male patient noticed blurry vision five days after his first dose of SARS-CoV-2 vaccination with Comirnaty�� and was diagnosed with venous stasis retinopathy in his left eye. A 67-year-old male was diagnosed with non-arteritic anterior ischemic optic neuropathy in his right eye four days after receiving the first dose of Vaxzevria�� (AstraZeneca��, Cambridge, UK). A 32-year-old man presented with a sudden onset of a scotoma two days after receiving the second dose of SARS-CoV-2 vaccination with Spikevax�� (Moderna, Cambridge, UK) and was diagnosed with a circumscribed nerve fiber infarction. A 21-year-old female patient developed an acute bilateral acute macular neuroretinopathy three days after receiving the first dose of SARS-CoV2-vaccine Vaxzevria�� (AstraZeneca��, Cambridge, UK). CONCLUSION This case series describes six cases of retinal vascular events shortly after receiving mRNA or adenoviral-vectored COVID-19 vaccines. The short time span between received vaccination and occurrence of the observed retinal vascular events raises the question of a direct correlation. Our case series adds to further reports of possible side effects with potential serious post-immunization complications of COVID-19 vaccinations. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
